Associated Vitreoretinal and Uveitis Consultants

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Macular degeneration3 trials
• Diabetic eye disease2 trials

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Recruiting3 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Amgen1 trial
• Boehringer Ingelheim1 trial
• EyeBiotech Ltd.1 trial
• Kodiak Sciences Inc1 trial
• Stealth BioTherapeutics Inc.1 trial

Running trials

• Recruiting

  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  NCT07614776· Phase 3· Amgen· Source

• Recruiting

  A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  NCT07440225· Phase 2/3· EyeBiotech Ltd.· Source

  Contact: Study Coordinator

• Recruiting

  A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

  NCT06962839· Phase 2· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

  NCT06373731· Phase 3· Stealth BioTherapeutics Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration2 recruiting
• Diabetic eye disease1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

  NCT06270836· Phase 3· Kodiak Sciences Inc· Source